Home › NDC Lookup › Ingredients › Miconazole Nitrate › 44577-0205-56
MacerRx Web MICONAZOLE NITRATE 2 g/100g Cream — NDC 44577-0205-56 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

MacerRx Web MICONAZOLE NITRATE 2 g/100g Cream — NDC 44577-205-56 (Billing 44577-0205-56)

by Clinical Therapeutic Solutions · 1 TUBE in 1 CARTON / 56 g in 1 TUBE

This is a package of MacerRx Web MICONAZOLE NITRATE 2 g/100g Cream from Clinical Therapeutic Solutions, marketed since Jun 2013 and currently FDA-listed. It is this product's only package size.

NDC 44577-0205-56
🏷️ FDA NDC (as labeled) 44577-205-56 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 44577-205-56 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
44577 labeler · 205 product · 56 package
Package marketed since
Feb 6, 2017
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 4457720556 8
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Miconazole Nitrate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 10, 2024 — Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0315-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 44577-205-56
Product NDC 44577-205
11-digit billing NDC 44577020556
RxCUI 998483, 1425866
UNII VW4H1CYW1K
Application # M005
SPL Set ID c9327f41-10f1-41f3-855b-838c701d6767
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2013-06-06
Route TOPICAL
Dosage form CREAM
Substance MICONAZOLE NITRATE
Quick answers
  • RxCUI (RxNorm): 998483
Why two NDCs? The FDA registers this code as 44577-205-56 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 44577-0205-56. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Imidazole derivatives, Imidazole and triazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats fungal and yeast infections. Depending on the product, that means vaginal yeast infections, athlete's foot, jock itch, ringworm, or thrush in the mouth and throat (Oravig...
  • Apply it to your upper gum in the morning after brushing, with dry hands. Hold it in place for 30 seconds. Don't crush, chew or swallow it. Use it once a day for 14 days.
  • Most are mild, like diarrhea, nausea, headache, upper belly pain or a change in taste. Vaginal products may cause mild burning or itching at first. Stop and get help for hives, tro...
  • Tell me if you take warfarin. Miconazole can boost its blood-thinning effect, so watch for bleeding or bruising. With Oravig, oral diabetes medicines, phenytoin and ergot alkaloids...
📖 Read our full Miconazole guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
44577-0205-56 You're viewing this Main listing 1 TUBE in 1 CARTON / 56 g in 1 TUBE 2017-02-06 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 70000-0718-01 Cardinal 1 tube $0.078 — Availability likely —
Antifungal Cream 2 g/100g 21922-0095-06 Encube 1 tube $0.079 — Availability likely —
Antifungal Cream 2 g/100g 68001-0481-45 BluePoint 1 tube $0.082 — Availability likely —
Miconazole Nitrate Cream USP, 2% 2 g/100g 70000-0340-01 Cardinal 28.4 g $0.082 — Availability likely —
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 00536-1375-75 Rugby 1 tube $0.121 — Availability likely —
Miconazole Nitrate 20 mg/g 70677-1000-01 STRATEGIC 1 tube $0.121 — Availability likely —
SUNMARK MICONAZOLE NITRATE antifungal 20 mg/g 49348-0689-72 Strategic 1 tube $0.122 — Availability likely —
Miconazole Nitrate 20 mg/g 51672-2001-01 Sun 1 tube $0.201 — Availability likely —
Selan Antifungal 2 g/100g 00159-2500-04 Trividia 117 g — — FDA listed —
Desenex Antifungal Foot Cream 20 mg/g 00316-0255-01 Crown 1 tube — — FDA listed —
Baza Antifungal 20 mg/g 11701-0045-14 Coloplast 142 g — — FDA listed —
MacerRx Web 2 g/100gthis 44577-0205-56 Clinical 1 tube — — FDA listed —
Miconazole Nitrate 20 mg/g 50090-1071-00 A-S 1 tube — — FDA listed —
Miconazole Nitrate 20 mg/g 50090-5607-00 A-S 1 tube — — FDA listed —
Miconazole Nitrate 20 mg/g 50090-5674-00 A-S 1 tube — — FDA listed —
Miconazole Nitrate 20 mg/g 50090-7364-00 A-S 1 tube — — FDA listed —
CAREALL Miconazole Nitrate 20 mg/g 51824-0078-01 New 28 g — — FDA listed —
Anti-Fungal .02 g/g 52000-0021-37 Universal 1 tube — — FDA listed —
Medline 20 mg/mL 53329-0147-44 Medline 118 ml — — FDA listed —
Remedy Antifungal With Olivamine 2 g/100g 53329-0162-04 Medline 113 g — — Discontinued —
Medline 20 mg/100g 53329-0218-44 Medline 113 g — — FDA listed —
ProCure Antifungal Cream 2 g/100g 55681-0023-04 Twin 106 g — — FDA listed —
ProCure Antifungal 2 g/100g 55681-0047-04 Twin 106 g — — FDA listed —
Lasolex AC 2 g/100g 59088-0239-07 PureTek 85 g — — FDA listed —
Conazol 20 mg/g 59208-0001-30 Laboratorios 30 g — — FDA listed —
Private Label Antifungal Barrier Cream 20 g/1000g 60232-0009-02 Swiss-American 60 g — — FDA listed —
BOA VIDA Antifungal 2 g/100g 62654-0147-01 Central 113 g — — FDA listed —
Micatin 20 mg/g 65197-0103-05 WellSpring 14 g — — FDA listed —
Antifungal 2 g/100g 67777-0710-02 Dynarex 144 packets — — FDA listed —
Miconazole 20 mg/g 68016-0291-01 Chain 1 tube — — FDA listed —
MICONAZOLE Nitrate 2 g/100g 68071-3429-03 NuCare 1 tube — — FDA listed —
Antifungal Body 2 mg/100mL 68599-0206-04 McKesson 118 ml — — FDA listed —
Miconazole Nitrate 2 mg/100mg 68599-1471-04 McKesson 118 mg — — FDA listed —
Antifungal Cream 2 g/100g 68788-8645-02 Preferred 1 tube — — FDA listed —
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 68788-8845-03 Preferred 1 tube — — FDA listed —
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 68788-8895-03 Preferred 1 tube — — FDA listed —
PiYanPing Antifungal 2 g/100g 69070-0304-01 Zhejiang 1 tube — — FDA listed —
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 69396-0014-05 Trifecta 15 g — — FDA listed —
FifthPulse Miconazole Nitrate Cream 1oz 20 mg/g 69571-0016-01 Front 28.4 g — — FDA listed —
FifthPulse Miconazole Nitrate Cream 4oz 2 g/100g 69571-0017-01 Front 113.4 g — — FDA listed —
Secura Antifungal Greaseless 20 mg/g 69740-0328-00 Smith 57 g — — FDA listed —
Secura Antifungal Extra Thick 20 mg/g 69740-0329-00 Smith 92 g — — FDA listed —
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 69771-0041-25 GERI-GENTLE 113 g — — FDA listed —
MICONAZOLE Nitrate 2% 2 g/100g 71399-0071-01 Akron 1 tube — — FDA listed —
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 77338-0041-25 ASTONEA 113 g — — FDA listed —
Athletes Foot 2 g/100mL 83004-0014-01 Rida 1 bottle — — FDA listed —
Fungazol Athlete Foot 2 g/100mL 83004-0025-01 Rida 1 bottle — — FDA listed —
Pharmlitalia Jock Itch Miconazole Nitrate 2 g/100mL 83004-0031-01 Rida 1 jar — — Discontinued —
ElixirTripleGuard Triple Antibiotic 2 g/100g 84546-0007-01 ELIXIR 113 g — — FDA listed —
Hermon Jock Itch Ringworm and athlete s foot cream 2 g/100g 84746-0008-01 Shandong 100 g — — Discontinued —
Nedtol Folliculitis Treatment Creams 2 g/100g 84867-0022-01 Jiashen 120 g — — FDA listed —
Beilloso Balanitis Relief 2 g/100mL 85248-0138-01 Jiangxi 30 ml — — FDA listed —
Inlifay ANTIFUNGAL 2 g/100g 85248-0139-01 Jiangxi 100 g — — FDA listed —
Charmpoo Antifungal Cream 2 g/100g 85248-0142-01 Jiangxi 100 g — — FDA listed —
Charmpoo Antifungal Cream 2 g/100g 85248-0212-01 Jiangxi 30 g — — FDA listed —
Charmpoo Antifungal Cream 2 g/100g 85248-0226-01 Jiangxi 2 tubes — — FDA listed —
BODYKOO ATHLETE FOOT Cream 2 g/100g 85248-0229-01 Jiangxi 30 g — — FDA listed —
Tagrid Jock Itch Miconazole Nitrate 2% 20 mg/g 85384-0003-01 TAGRID 100 g — — FDA listed —
Ringworm Treatment Cream 2 g/100g 85398-0024-01 Beautivity 100 g — — FDA listed —
Hermon Jock Itch Antifungal Treatment Cream 1.2 g/60g 85398-0032-01 Beautivity 60 g — — FDA listed —
RoyceDerm Tinea Antifungal Cream 20 mg/g 85424-0011-01 RoyceDerm 57 g — — FDA listed —
RoyceDerm Anti-Fungal Cream 2 g/100g 85424-0021-01 RoyceDerm 100 g — — FDA listed —
Aosorw Antifungal Cream 2 g/100g 85498-0011-01 SpineStatus 120 g — — FDA listed —
Kerova Miconazole Nitrate 2 g/100g 85959-0001-01 Guangzhou 100 g — — FDA listed —
Recuren Plus Antifungal Cream 20 mg/g 87014-0001-01 REGENEREN 100 g — — FDA listed —
Recuren Plus Jock Itch Cream 20 mg/g 87014-0004-01 REGENEREN 30 g — — FDA listed —
Kopa Haiku Antifungal Cream 20 mg/g 87041-0001-01 Trovina 100 g — — FDA listed —
Kopa Haiku Antifungal Cream 20 mg/g 87041-0002-01 Trovina 30 g — — FDA listed —
Kopa Haiku Antifungal Cream 20 mg/g 87041-0004-01 Trovina 60 g — — FDA listed —
Kopa Haiku Ringworm Treatment Cream 20 mg/g 87041-0008-01 Trovina 30 g — — FDA listed —
Miconazole Cream 2 g/100g 87236-0013-04 Aldermed 113 g — — FDA listed —
Doctor Jiao Antifungal Cream 2 g/100g 87537-0002-02 Jiangxi 1 tube — — FDA listed —
Lasolex AG 2 g/100g 59088-0207-07 Puretek 85 g — — FDA listed —
Femmesil Maximum Strength 2 g/100g 24909-0202-28 Aidance 1 bottle — — Discontinued —
White Tetterine 2 g/100g 12258-0242-01 S.S.S. 1 tube — — FDA listed —
Triple Antifungal 2 g/100g 16864-0040-02 Advantice 1 tube — — FDA listed —
Green Tetterine 2 g/100g 12258-0241-01 S.S.S. 1 can — — FDA listed —
Claravie 2 g/100g 61554-0305-11 Gentell 113 g — — FDA listed —
MOROVANJock Itch Antifungal 2 g/100g 87800-0006-01 HONG 100 g — — FDA listed —
Hermon Jock Itch Ringworm Athletes Foot Cream 2 g/100g 85398-0036-01 Beautivity 100 g — — FDA listed —
Fgper Antifungal 2 g/100g 85593-0140-01 Guangzhou 100 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2013
On the market since
Jun 2013
📍
2026
Currently FDA-listed
13 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Miconazole inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII Q40Q9N063P
    Acetic acid is a weak organic acid commonly used in medicines as a buffer and pH adjuster. It helps maintain the proper acidity level to ensure the drug remains stable and effective in its formulation.
  • UNII 0A5MM307FC
    A synthetic polymer that absorbs water and forms a thick, gel-like substance. In medicines, it works as a thickener and stabilizer to improve texture and help ingredients stay mixed together in creams, gels, and lotions.
  • UNII 9H4PO4Z4FT
    A sulfur-containing organic compound used as a solvent and penetration enhancer in medicines. It helps dissolve active ingredients and improve their absorption through skin or mucous membranes.
  • UNII 147D247K3P
    Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
  • UNII T4V6TWG28D
    A plant-derived thickening agent made from cellulose. It increases viscosity and helps form a gel or paste consistency in medications, and may serve as a binder or coating material in various formulations.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII VIF565UC2G
    Tea tree oil is an essential oil extracted from the leaves of the Australian tea tree plant. In medicines, it typically serves as a flavoring agent, fragrance, or antimicrobial component in topical formulations.
  • UNII 9O3K93S3TK
    Trolamine is an alkaline compound used as a pH buffer and emulsifier in medicines. It helps neutralize acids, stabilize formulations, and enable mixing of oil and water-based ingredients.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII 101I4J0U34
    Witch hazel is a plant extract obtained from the leaves and bark of the North American shrub Hamamelis virginiana. It functions as an astringent and skin-conditioning agent in topical products, helping to tone and prepare the skin.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAcetic Acid, Aqua (Deionized Water), Carbomer, Ethylhexylglycerin, Hamamelis Virginiana (Witch Hazel) Distillate, Hydroxyethylcellulose, Melaleuca Alternifolia (Tea Tree Oil), Methylsulfonylmethane (MSM), Phenoxyethanol, SD-Alcohol, Triethanolamine

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerClinical Therapeutic Solutions
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code44577
First marketedJun 2013
Product typeHuman Otc Drug
Portfolio9 products on file

More NDCs from Clinical Therapeutic Solutions labeler code 44577

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 46 words ▾

Uses: Proven clinically to cure most: athlete’s foot (tinea pedis) ringworm (tinea corporis) Effectively soothese and relieves: itching burning cracking Helps prevent most athlete’s foot from coming back with daily use For the treatment of superficial skin infections caused by yeast (Candida albicans, intertrigo) and erythrasma

⏱️ Dosage and Administration 87 words ▾

Directions: clean the affected area and dry thoroughly apply a thin layer over the affected area twice daily (morning and night) supervise children in the use of this product for athlete’s foot, pay special attention to the spaces between toes. Wear well-fitting, ventilated shoes, and change shoes and socks at least once daily use daily for 4 weeks. If condition lasts longer, ask a doctor to prevent athlete’s foot, apply to the feet once or twice daily this product is not effective on the scalp or nails

⚠️ Warnings 51 words ▾

Warnings: For external use only When using this product: Avoid contact with eyes Stop use and ask a doctor if: Irritation occurs There is no improvement within 4 weeks Keep out of reach of children. If swallowed, contact physician or poison control center immediately. Store at room temperature 68-77ºF (20-25º C)

📦 Storage and Handling 7 words ▾

Store at room temperature 68-77ºF (20-25º C)

🧪 Active Ingredient 6 words ▾

Active Ingredient: -Miconazole Nitrate 2.00% Antifungal

🧪 Inactive Ingredients 25 words ▾

Other Ingredients: Acetic Acid, Aqua (Deionized Water), Carbomer, Ethylhexylglycerin, Hamamelis Virginiana (Witch Hazel) Distillate, Hydroxyethylcellulose, Melaleuca Alternifolia (Tea Tree Oil), Methylsulfonylmethane (MSM), Phenoxyethanol, SD-Alcohol, Triethanolamine

🎯 Purpose 1 words ▾

Antifungal

📄 When Using This Product 8 words ▾

When using this product: Avoid contact with eyes

📄 Stop Use and Ask a Doctor If 16 words ▾

Stop use and ask a doctor if: Irritation occurs There is no improvement within 4 weeks

📄 Keep Out of Reach of Children 15 words ▾

Keep out of reach of children. If swallowed, contact physician or poison control center immediately.

📄 Package Label / Principal Display Panel 3 words ▾

Package Labeling: Label00

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Miconazole 3 (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Miconazole 3. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$35.6K
Claims incl. refills
725
Beneficiaries
649
Spend / beneficiary
$54.91
Spend / claim
$49.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for MacerRx Web (this brand).

Top reported reactions

Vulvovaginal Burning Sensation242
Vulvovaginal Pain79
Vulvovaginal Pruritus73
Condition Aggravated72
Drug Interaction58
Vulvovaginal Discomfort47
Vaginal Haemorrhage42

Reporter sex

1,338 reports
Male · 24%
Female · 76%
Unknown · 0%

Serious outcomes

Hospitalization303
Death85
Life-threatening53
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 140 94
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Clinical Therapeutic Solutions. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Clinical Therapeutic Solutions is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 44577-0128-00 · Clinical 44577-0470-00 · Clinical →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.